Simvastatin
Product Images NDC 43353-768

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Simvastatin (NDC 43353-768). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label (43353 768)

Bottle Label (43353 768)
Simvastatin 80 mg tablet bottle label showing package quantity of 15 tablets. The label includes directions to store between 20-25 degrees Celsius and warnings to keep out of children's reach. It states the product is repackaged by Aphena Pharma Solutions - Tennessee, Inc. with manufacturing by Blu Caribe in Dorado, Puerto Rico. Barcodes and NDC number 43353-0768-15 are visible.*
FDA Label Image

Bottle Label (43353 773)

Bottle Label (43353 773)
Simvastatin 20 mg tablets packaging label showing a supply of 15 tablets. Label includes storage instructions, manufacturer Blu Caribe in Dorado, PR, and repackager Aphena Pharma Solutions - Tennessee, Inc. The label bears NDC 43353-0773-15 with usage restricted to prescription only.*
FDA Label Image

Image Of Chemical Structure (Simvastatin 1)

Image Of Chemical Structure (Simvastatin 1)
Chemical structure diagram of Simvastatin showing its molecular arrangement with carbon, hydrogen, and oxygen atoms explicitly depicted as part of the lactone ring and side chains.*
FDA Label Image

The Effects Of Treatment With Simvastatin On Major Vascular Events And Major Coronary Events In Hps (Simvastatin 2)

The Effects Of Treatment With Simvastatin On Major Vascular Events And Major Coronary Events In Hps (Simvastatin 2)
Forest plots showing the incidence (%) and risk ratios with 95% confidence intervals for major vascular and major coronary events comparing Simvastatin versus placebo across various patient subgroups categorized by baseline characteristics such as presence of coronary heart disease, diabetes mellitus, peripheral vascular disease, cerebrovascular disease, gender, age, LDL-cholesterol, and HDL-cholesterol levels.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.